Diagnostik und Therapie

Bild von StockSnap auf Pixabay



1. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldmanmd AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SC, Jr.: ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001; 104: 2996-3007.

2. Blackledge HM, Newton J, Squire IB: Prognosis for South Asian and white patients newly admitted to hospital with heart failure in the United Kingdom: historical cohort study. Bmj 2003; 327: 526-31.

3. Wollert KC, Drexler H: Akute Herzinsuffizienz. Internist (Berl) 1998; 39: 459-66.

4. Felker GM, Adams KF, Jr., Konstam MA, O'Connor CM, Gheorghiade M: The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J 2003; 145: S18-25.

5. Riegger GA, Muders F, Luchner A: Neurohumorale Regulation in der Herzinsuffizienz. Z Kardiol 1996; 85 Suppl 6: 205-10.

6. de Lemos JA, McGuire DK, Drazner MH: B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316-22.

7. Webb AR: Management of acute heart failure. Minerva Anestesiol 2002; 68: 196-200.

8. Poelaert J, Schmidt C, Colardyn F: Transoesophageal echocardiography in the critically ill. Anaesthesia 1998; 53: 55-68.

9. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE, 3rd, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson A, Jr., Gregoratos G, Smith SC, Jr.: 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999; 100: 1016-30.

10. Sharma A, Hermann DD, Mehta RL: Clinical benefit and approach of ultrafiltration in acute heart failure. Cardiology 2001; 96: 144-54.

11. Perret C, Enrico JF: Manipulating afterload for the treatment of acute heart failure. A historical summary. Intensive Care Med 2003; 29: 364-7.

12. Fonarow GC: The treatment targets in acute decompensated heart failure. Rev Cardiovasc Med 2001; 2 Suppl 2: S7-S12.

13. DeWood MA, Notske RN, Hensley GR, Shields JP, O'Grady WP, Spores J, Goldman M, Ganji JH: Intraaortic balloon counterpulsation with and without
reperfusion for myocardial infarction shock. Circulation 1980; 61: 1105-12.

14. Weisse U, Isgro F, Werling C, Lehmann A, Saggau W: Impact of atriobiventricular pacing to poor left-ventricular function after CABG. Thorac Cardiovasc Surg 2002; 50: 131-5.

15. Crystal E, Healey J, Connolly SJ: Atrial fibrillation after cardiac surgery: update on the evidence on the available prophylactic interventions. Card Electrophysiol Rev 2003; 7: 189-92.

16. Lowson SM, Doctor A, Walsh BK, Doorley PA, Haraldsson s A, Kieler-Jensen N, Ricksten SE: Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension. Crit Care Med 2002; 30: 2762-4.

17. Haraldsson s A, Kieler-Jensen N, Ricksten SE: The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension. Anesth Analg 2001; 93: 1439-45, table of contents.

18. O'Connor CM, Gattis WA, Uretsky BF, Adams KF, Jr., McNulty SE, Grossman SH, McKenna WJ, Zannad F, Swedberg K, Gheorghiade M, Califf RM: Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1999; 138: 78-86.

19. Koerner MM, Loebe M, Lisman KA, Stetson SJ, Lafuente JA, Noon GP, Torre- Amione G: New strategies for the management of acute decompensated heart failure. Curr Opin Cardiol 2001; 16: 164-73.

20. Young JB: New therapeutic choices in the management of acute congestive heart failure. Rev Cardiovasc Med 2001; 2 Suppl 2: S19-24.

21. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L: Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360: 196-202.

22. Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W: Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 2000; 102: 2222-7.

23. Stevenson LW, Rose EA: Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom? Circulation 2003; 108:

24. Willerson JT, Kereiakes DJ: Editors' commentary: mechanical circulatory support. Circulation 2003; 108: 3069-70.

zwai.net // Journal - Portal - Forum - Weiterbildung für Anästhesie- und Intensivpflege // ein Dienst der zwai.media GbR